Aggressive pituitary tumours and pituitary carcinomas

G Raverot, MD Ilie, H Lasolle, V Amodru… - Nature Reviews …, 2021 - nature.com
Although usually benign, anterior pituitary tumours occasionally exhibit aggressive
behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional …

[HTML][HTML] How to classify pituitary neuroendocrine tumors (PitNET) s in 2020

J Trouillas, ML Jaffrain-Rea, A Vasiljevic, G Raverot… - Cancers, 2020 - mdpi.com
Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors
(PitNET), are mostly benign, but may present various behaviors: invasive,“aggressive” and …

The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new

P Chanson, D Maiter - Best practice & research Clinical endocrinology & …, 2019 - Elsevier
Prevalence and incidence of prolactinomas are approximately 50 per 100,000 and 3–5 new
cases/100,000/year. The pathophysiological mechanism of hyperprolactinemia-induced …

[PDF][PDF] Position statement for clinical practice: prolactin-secreting tumors

R Cozzi, MR Ambrosio, R Attanasio… - European Journal of …, 2022 - research.unipd.it
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin …

R Cozzi, MR Ambrosio, R Attanasio… - European journal of …, 2022 - academic.oup.com
Prolactinomas are the most frequent pituitary adenomas. Prolactinoma may occur in different
clinical settings and always require an individually tailored approach. This is the reason why …

A Cancer Cell Selective Replication Stress Nano Amplifier Promotes Replication Fork Catastrophe to Overcome Radioresistance

H Liao, S Yang, Z Liang, L Xiao, S Xie, P Lin, F Xia… - ACS …, 2023 - ACS Publications
Replication stress (RS) induced by DNA damage plays a significant role in conferring the
anticancer effects of radiotherapy and is tightly associated with radioresistance of cancer …

Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours

J Simon, LG Perez-Rivas, Y Zhao… - European journal of …, 2023 - academic.oup.com
Objective A somatic mutational hotspot in the SF3B1 gene was reported in lactotroph
tumours. The aim of our study was to examine the prevalence of driver SF3B1 variants in a …

Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?

DA Niculescu, ML Gheorghiu… - European Journal of …, 2023 - academic.oup.com
Radiotherapy, conventional or radiosurgery, has been used to control prolactin secretion
and tumour growth in prolactinomas both as part of multimodal therapy or rarely as primary …

Immune landscape of pituitary tumors reveals association between macrophages and gonadotroph tumor invasion

M Principe, M Chanal, MD Ilie, A Ziverec… - The Journal of …, 2020 - academic.oup.com
Abstract Purpose Pituitary neuroendocrine tumors (PitNETs) are frequent intracranial
neoplasms that present heterogenic characteristics. Little is known about the immune cell …

[HTML][HTML] Refractory lactotroph adenomas

SA Urwyler, N Karavitaki - Pituitary, 2023 - Springer
A small subset of lactotroph adenomas is resistant to dopamine agonists (DA) and can also
demonstrate aggressive or even malignant behavior. The implicated mechanisms are not …